Literature DB >> 7157360

[Pharmacokinetics of arsenic trioxide in the mouse].

C Brunet, M Luyckx, M Cazin.   

Abstract

Considering the diversity of previous observations given by literature about the metabolic fate or arsenic, the authors using a radioactive tracer, study the pharmacokinetics of that arsenical derivative after giving the mouse a non toxic dose. By the oral route, this compound is quickly absorbed and resorbed. The elimination process mainly occurs by renal route then by the faecal route. The blood results or the concentrations in the tissues do not reveal any retention process though the latter always rise above blood levels. During the first two hours the concentrations in the thymus seem to be particularly interesting.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7157360

Source DB:  PubMed          Journal:  Toxicol Eur Res        ISSN: 0249-6402


  2 in total

1.  A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.

Authors:  Richard W Ahn; Feng Chen; Haimei Chen; Stephan T Stern; Jeffrey D Clogston; Anil K Patri; Meera R Raja; Elden P Swindell; Vamsi Parimi; Vincent L Cryns; Thomas V O'Halloran
Journal:  Clin Cancer Res       Date:  2010-06-02       Impact factor: 12.531

2.  Size control of arsenic trioxide nanocrystals grown in nanowells.

Authors:  Eun-Ah You; Richard W Ahn; Min Hyung Lee; Meera R Raja; Thomas V O'Halloran; Teri W Odom
Journal:  J Am Chem Soc       Date:  2009-08-12       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.